Literature DB >> 18340093

Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke.

Hakan Ay1, E Murat Arsava, Jonathan Rosand, Karen L Furie, Aneesh B Singhal, Pamela W Schaefer, Ona Wu, R Gilberto Gonzalez, Walter J Koroshetz, A Gregory Sorensen.   

Abstract

BACKGROUND AND
PURPOSE: Leukoaraiosis (LA) is associated with structural and functional vascular changes that may compromise tissue perfusion at the microvascular level. We hypothesized that the volume of LA correlated with the proportion of initially ischemic but eventually infarcted tissue in acute human stroke.
METHODS: We studied 61 consecutive patients with diffusion-weighted imaging-mean transit time mismatch. All patients were scanned twice within 12 hours of symptom onset and between days 4 and 30. We explored the relationship between the volume of white matter regions with LA on acute images and the proportion of diffusion-weighted imaging-mean transit time mismatch tissue that progressed to infarction (percentage mismatch lost).
RESULTS: Bivariate analyses showed a statistically significant correlation between percentage mismatch lost and LA volume (r=0.33, P<0.01). A linear regression model with percentage mismatch lost as response and LA volume, acute diffusion-weighted imaging and mean transit time volumes, age, admission blood glucose level, admission mean arterial blood pressure, etiologic stroke subtype, time to acute MRI, and time between acute and follow-up imaging as covariates revealed that LA volume was an independent predictor of infarct growth (P=0.04). The adjusted percentage mismatch lost in the highest quartile of LA volume was 1.9-fold (95% CI: 1.2 to 3.1) greater than the percentage mismatch lost in the lowest quartile.
CONCLUSIONS: LA volume at the time of acute ischemic stroke is a predictor infarct growth. Because LA is associated with factors that modulate tissue perfusion as well as tissue capacity for handling of ischemia, LA volume appears to be a composite predictive marker for the fate of acutely ischemic tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18340093     DOI: 10.1161/STROKEAHA.107.501932

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  60 in total

1.  Reduced Ischemic Lesion Growth with Heparin in Acute Ischemic Stroke.

Authors:  Eva A Rocha; Ruijun Ji; Hakan Ay; Zixiao Li; Ethem Murat Arsava; Gisele S Silva; Alma Gregory Sorensen; Ona Wu; Aneesh B Singhal
Journal:  J Stroke Cerebrovasc Dis       Date:  2019-03-29       Impact factor: 2.136

Review 2.  Leukoaraiosis and stroke.

Authors:  Eric E Smith
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

Review 3.  Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates.

Authors:  Jeremy D Schmahmann; Eric E Smith; Florian S Eichler; Christopher M Filley
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 4.  Clinical neurogenetics: stroke.

Authors:  Natalia S Rost
Journal:  Neurol Clin       Date:  2013-07-17       Impact factor: 3.806

5.  Setting a gold standard for quantification of leukoaraiosis burden in patients with ischemic stroke: the Atherosclerosis Risk in Communities Study.

Authors:  Natalia S Rost; Saloomeh Sadaghiani; Alessandro Biffi; Kaitlin M Fitzpatrick; Lisa Cloonan; Jonathan Rosand; Dean K Shibata; Thomas H Mosley
Journal:  J Neurosci Methods       Date:  2014-01-15       Impact factor: 2.390

6.  White matter burden does not influence the outcome of mechanical thrombectomy.

Authors:  Laura Mechtouff; Norbert Nighoghossian; Camille Amaz; Marielle Buisson; Yves Berthezène; Laurent Derex; Elodie Ong; Omer Faruk Eker; Tae-Hee Cho
Journal:  J Neurol       Date:  2019-11-08       Impact factor: 4.849

7.  Severity of leukoaraiosis in large vessel atherosclerotic disease.

Authors:  A Chutinet; A Biffi; A Kanakis; K M Fitzpatrick; K L Furie; N S Rost
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

8.  White matter hyperintensity volume correlates with matrix metalloproteinase-2 in acute ischemic stroke.

Authors:  Zachary A Corbin; Natalia S Rost; Svetlana Lorenzano; Walter N Kernan; Michael K Parides; Jeffrey B Blumberg; Paul E Milbury; Ken Arai; Sophia N Hartdegen; Eng H Lo; Steven K Feske; Karen L Furie
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-01-16       Impact factor: 2.136

9.  A score to predict early risk of recurrence after ischemic stroke.

Authors:  H Ay; L Gungor; E M Arsava; J Rosand; M Vangel; T Benner; L H Schwamm; K L Furie; W J Koroshetz; A G Sorensen
Journal:  Neurology       Date:  2009-12-16       Impact factor: 9.910

10.  Leukoaraiosis predicts a poor 90-day outcome after endovascular stroke therapy.

Authors:  J Zhang; A S Puri; M A Khan; R P Goddeau; N Henninger
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.